We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,161 results
  1. Clinical and Pathopsychological Characteristics of Juvenile Depression with Attenuated Schizophrenic Spectrum Symptoms

    Objectives. To identify the clinical and pathopsychological features of juvenile depression with attenuated schizophrenia spectrum symptoms, as well...

    M. A. Omelchenko, Yu. A. Atadzhykova, ... V. G. Kaleda in Neuroscience and Behavioral Physiology
    Article 01 March 2022
  2. Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients

    Background

    Blastocystis sp. is one of the most common colonisers of the intestinal tract that demonstrate strong interaction with accompanying gut...

    Freddy Franklin, Arutchelvan Rajamanikam, ... Suresh Kumar in Parasites & Vectors
    Article Open access 05 September 2022
  3. Schizophrenic Syndromes: Schizophrenia

    Schizophrenia is a mental illness found around the world, usually afflicting around 1% of the population. Far beyond what this moderate prevalence...
    Andreas Meyer-Lindenberg in Neuroscience in the 21st Century
    Reference work entry 2022
  4. Pilot Study of the DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, and ABCB1 Gene Expression in Peripheral Blood Leukocytes in Schizophrenic Patients with Metabolic Syndrome

    Abstract —Many individuals with schizophrenia also suffer from metabolic syndrome (MetS), which is a major risk factor for the development of...

    A. S. Boiko, D. Z. Paderina, ... S. A. Ivanova in Neurochemical Journal
    Article Open access 01 March 2024
  5. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients

    Clozapine (Clz) is an atypical antipsychotic, which its pharmacokinetics can be influenced by several factors. The CYP1A2 and CYP2C19, major enzymes...

    Helmi Ammar, Zohra Chadli, ... Karim Aouam in The Pharmacogenomics Journal
    Article 17 March 2021
  6. Effects of the COVID-19 Pandemic on the Occurrence and Course of Mental Disorders in Elderly People

    Objectives . To study the impact of COVID-19 on the occurrence and course of mental illness in hospitalized elderly patients. Materials and methods ....

    O. B. Yakovleva, T. P. Safarova, D. A. Tsvetaeva in Neuroscience and Behavioral Physiology
    Article 01 November 2023
  7. A Diagnostic Perspective of Schizophrenia: From Past to Present

    Schizophrenia is a chronic manic-depressive illness. It is a mental illness characterized by a combination of symptoms such as perceptual...
    Meghna R. Choudhari, Indranath Chatterjee in Cognizance of Schizophrenia:: A Profound Insight into the Psyche
    Chapter 2023
  8. The neurodevelopmental basis of schizophrenia: clinical clues from craniofacial dysmorphology in northwest Ethiopia, 2020

    Background

    The neurodevelopmental speculation of schizophrenia states that the pathogenesis of schizophrenia starts with early fetal or neonatal...

    Binalfew Tsehay, Girma Seyoum in BMC Neuroscience
    Article Open access 29 September 2021
  9. Decreased gray matter volume is associated with theory of mind deficit in adolescents with schizophrenia

    Schizophrenia patients often suffer from deficit in theory of mind (TOM). Prior neuroimaging studies revealed neuroimaging correlates of TOM deficit...

    Yanmei Shen, Xue** Gao, ... Ruiyang Ge in Brain Imaging and Behavior
    Article 21 January 2022
  10. Facial emotion perception abilities are related to grey matter volume in the culmen of cerebellum anterior lobe in drug-naïve patients with first-episode schizophrenia

    Impaired capability for understanding and interpreting the expressions on other people's faces manifests itself as a core feature of schizophrenia,...

    **aoxin Zhao, **g**g Yao, ... Yuxiu Sui in Brain Imaging and Behavior
    Article 25 June 2022
  11. Recent advancements in biomarker research in schizophrenia: map** the road from bench to bedside

    Schizophrenia (SZ) is a severe progressive neurodegenerative as well as disruptive behavior disorder affecting innumerable people throughout the...

    Shivangi Patel, Dilip Sharma, ... Vinod Tiwari in Metabolic Brain Disease
    Article 03 March 2022
  12. Artificial Intelligence: The Future of Individualized and Effective Healthcare Approach for Psychosis

    Every year, the incidence and prevalence of mental diseases rise. There has been a spike in drug usage, loneliness, and suicidal ideation because of...
    Krish Patel, Shannon Kim, ... Muralikrishnan Dhanasekaran in Application of Artificial Intelligence in Neurological Disorders
    Chapter 2024
  13. The atypic antipsychotic clozapine inhibits multiple cardiac ion channels

    Clozapine is an atypical neuroleptic used to manage treatment-resistant schizophrenia which is known to inhibit cardiac hERG/K V 11.1 potassium...

    Marguerite Le Marois, Camille Sanson, ... G. Andrees Bohme in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 29 October 2022
  14. Different Phases of Schizophrenia Patients: From the Psychological Perspective

    The primary purpose of this chapter is to review current clinical staging information in schizophrenia spectrum disorders. In the last two decades,...
    Abdul Moiz Sahito, Mohammad Mehedi Hasan, ... Shabana Bibi in Cognizance of Schizophrenia:: A Profound Insight into the Psyche
    Chapter 2023
  15. The Structure of Catatonia in Depression and Depressive-Delusional States

    Objectives. To identify the psychopathological structure of catatonia and highlight its most significant components in depressive and...

    M. I. Bolgov, A. N. Barkhatova in Neuroscience and Behavioral Physiology
    Article 01 February 2023
  16. Neuroinflammation and Microglial Activation in Schizophrenia: An Overview

    Schizophrenia has been classified recently to be initiated as a neuroinflammatory disorder that may upgrade later into neurodegenerative one. There...
    Living reference work entry 2023
  17. Risky sexual behaviors of schizophrenic patients: a single center study in Ethiopia, 2018

    Objective

    Identify factors related to risky sexual behavior can facilitate health care providers to approach programs that improve quality of services...

    Biruk Negash, Bethlehem Asmamewu, Wondale Getinet Alemu in BMC Research Notes
    Article Open access 27 September 2019
  18. Evaluating Ratio Indices Based on Electroencephalogram Brainwaves in Schizophrenia Detection

    Purpose

    Extensive research has been conducted by neurocognitive and psychological scientists to diagnose mental and neurological diseases...

    Atefeh Goshvarpour, Ateke Goshvarpour in Journal of Medical and Biological Engineering
    Article 12 February 2024
  19. Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries

    Purpose

    The aim of the present study was to describe antipsychotic utilization patterns among patients with schizophrenic disorder in Italy, Spain,...

    Janet Sultana, Isabel Hurtado, ... Gianluca Trifirò in European Journal of Clinical Pharmacology
    Article 01 March 2019
  20. Reduced Number Density of Oligodendrocytes and Oligodendrocyte Clusters in the Head of the Caudate Nucleus in Schizophrenia

    Objectives . To carry out a morphometric evaluation of the number density of oligodendrocytes (NvOl) and oligodendrocyte clusters (NvOlC) in the...

    N. S. Kolomeets, N. A. Uranova in Neuroscience and Behavioral Physiology
    Article 01 September 2023
Did you find what you were looking for? Share feedback.